Skip to content

Opening book details…

About this Medicine article

PF285 ZELLA-101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS by Lee, D.; Smith, B.; Frattini, M.; Anthony, S.; Bearss, D.; Zeidner, J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Lee, D.; Smith, B.; Frattini, M.; Anthony, S.; Bearss, D.; Zeidner, J.
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Ovid Technologies (Wolters Kluwer Health) (ISSN 2572-9241)
Published
2019
Field
Medicine (Health Sciences)

More by Lee, D.; Smith, B.; Frattini, M.; Anthony, S.; Bearss, D.; Zeidner, J.

Browse all works by Lee, D.; Smith, B.; Frattini, M.; Anthony, S.; Bearss, D.; Zeidner, J.